Pharmaceutical pricing: what is reasonable?

methodsNTvG

Aug 18

Written By Matthijs Versteegh

Methods

Matthijs Versteegh

Ravulizumab for paroxysmal nocturnal haemoglobinuria: a Single Technology Assessment

Evaluation of the performance of algorithms mapping EORTC QLQ-C30 onto the EQ-5D index in a metastatic colorectal cancer cost-effectiveness model